EXEL

Exelixis, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$43.88

Market Cap

$11.76B

Beta

0.42

P/E

15.8

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+6.98%

EPS Growth (YoY)+57.95%

Revenue CAGR 3Y+12.93%

P/E Ratio15.8

PEG Ratio0.27

FCF Yield+7.30%

Debt / Equity0.08

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for EXEL.